Prevention of scopolamine-induced memory deficits by schisandrin B, an antioxidant lignan from Schisandra chinensis in mice

Free Radical Research

Volumn 45, Issue 8, 2011, Pages 950-958

  Giridharan, Vijayasree V ^a   Thandavarayan, Rajarajan A ^a   Sato, Shinji ^a   Ko, Kam Ming ^b   Konishi, Tetsuya ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Acetylcholinesterase; Antioxidant; Oxidative stress; Schisandrin b

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; NITRITE; SCHIZANDRIN B; SCOPOLAMINE; TACRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; BRAIN FUNCTION; CONFERENCE PAPER; CONTROLLED STUDY; DEMENTIA; ENZYME ACTIVITY; LEARNING DISORDER; MALE; MAZE TEST; MEDICINAL PLANT; MEMORY DISORDER; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; SCHISANDRA CHINENSIS; TASK PERFORMANCE;

ACETYLCHOLINESTERASE; ANIMALS; ANTIOXIDANTS; CYCLOOCTANES; LIGNANS; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; POLYCYCLIC COMPOUNDS; SCHISANDRA; SCOPOLAMINE HYDROBROMIDE;

MUS; SCHISANDRA CHINENSIS;

EID: 79960099131     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2011.571682     Document Type: Conference Paper

References (49)

1. Scarpini E, Scheltens P, Feldman H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol 2003;2:539-547. (Pubitemid 36994993)
2. Namba T, Nolte CT, Jackrel J, Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med 1971;50:475-492.
3. Ellis JM. Cholinesterase inhibitors in the treatment of dementia. J Am Osteopath Assoc 2005;105:145-158. (Pubitemid 40604672)
4. Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J. A controlled trial of tacrine in Alzheimer ' s disease. The Tacrine Study Group. JAMA 1992;268: 2523-2529.
5. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer ' s disease. The Tacrine Study Group. JAMA 1994;271:985-991. (Pubitemid 24099918)
6. Lahiri DK, Farlow MR, Grieg NH, Sambamurti K. Current drug targets for Alzheimer ' s disease treatment. Drug Dev Res 2002;56:267-281. (Pubitemid 35168304)
7. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer ' s disease. Donepezil Study group. Neurology 1998;50:136-145.
8. Zhao B. Natural antioxidants protect neurons in Alzheimer' s disease and Parkinson ' s disease. Neurochem Res 2009;34: 630-638.
9. Hatip-Al-Khatib I, Egashira N, Mishima K, Iwasaki K, Iwasaki K, Kurauchi K, Inui K, Ikeda T, Fujiwara M. Determination of the effectiveness of components of the herbal medicine Toki-Shakuyaku-San and fractions of Angelica acutiloba in improving the scopolamine-induced impairment of rat ' s spatial cognition in eight-armed radial maze test. J Pharmacol Sci 2004;96:33-41. (Pubitemid 39318776)
10. Kang SY, Lee KY, Park MJ, Kim YC, Markelonis GJ, Oh TH, Kim YC. Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice. Neurobiol Learn Mem 2003;79:11-18. (Pubitemid 36071185)
11. Kang SY, Lee KY, Koo KA, Yoon JS, Lim SW, Kim YC, Sung SH. ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis , signifi cantly improved scopolamine-induced memory impairment in mice. Life Sci 2005;76:1691-1705. (Pubitemid 40215212)
12. Houghton PJ, Agbedahunsi JM, Adegbulugbe A. Choline esterase inhibitory properties of alkaloids from two Nigerian Crinum species. Phytochemistry 2004;65:2893-2896. (Pubitemid 40292121)
13. Yamada N, Hattori A, Hayashi T, Nishikawa T, Fukuda H, Fujino T. Improvement of scopolamine-induced memory impairment by Z-ajoene in the water maze in mice. Pharmacol Biochem Behav 2004;78:787-791. (Pubitemid 39037740)
14. Yan JJ, Kim DH, Moon YS, Jung JS, Ahn EM, Baek NI, Song DK. Protection against beta-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:25-30.
15. Yu MS, Leung SK, Lai SW, Che CM, Zee SY, So KF, Yuen WH, Chang RC. Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicity. Exp Gerontol 2005;40:716-727. (Pubitemid 41265822)
16. Moreira PI, Zhu X, Liu Q, Honda K, Siedlak SL, Harris PL, Smith MA, Perry G. Compensatory responses induced by oxidative stress in Alzheimer disease. Biol Res 2006;39: 7-13. (Pubitemid 44027641)
17. El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary Eel D. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav 2003;76:525-533. (Pubitemid 37487909)
18. Chiu PY, Leung HY, Poon MK, Ko KM. Chronic schisandrin B treatment improves mitochondrial antioxidant status and tissue heat shock protein production in various tissues of young adult and middle-aged rats. Biogerontology 2006;7: 199-210.
19. Mak DH, Ip SP, Li PC, Poon MK, Ko KM. Effects of Schisandrin B and alpha-tocopherol on lipid peroxidation, in vitro and in vivo . Mol Cell Biochem 1996;20:161-165. (Pubitemid 26421268)
20. Zhu YP. Chinese materia medica chemistry, pharmacology and applications. The Netherlands: Harwood Academic Publishers; 1998. p. 653-657.
21. Liu GT. Pharmacological actions and clinical use of fructus schizandrae. Chin Med J 1989;102:740-749.
22. Ko KM, Mak D. Schisdandrin B and other dibenzocyclooctadiene lignans. New York: Marcel Dekker; 2004.
23. Xuejiang W, Magara T, Konishi T. Prevention and repair of cerebral ischemia-reperfusion injury by Chinese herbal medicine, shengmai san, in rats. Free Radic Res 1999;31: 449-455. (Pubitemid 29531125)
24. Nishida H, Kushida M, Nakajima Y, Ogawa Y, Tatewaki N, Sato S, Konishi T. Amyloid-beta-induced cytotoxicity of PC-12 cell was attenuated by Shengmai-san through redox regulation and outgrowth induction. J Pharmacol Sci 2007;104:73-81. (Pubitemid 46790318)
25. Kim DH, Hung TM, Bae KH, Jung JW, Lee S, Yoon BH, Cheong JH, Ko KH, Ryu JH. Gomisin A improves scopolamine- induced memory impairment in mice. Eur J Pharmacol 2006;542:129-135. (Pubitemid 44088401)
26. Egashira N, Kurauchi K, Iwasaki K, Mishima K, Orito K, Oishi R, Fujiwara M. Schizandrin reverses memory impairment in rats. Phytother Res 2008;22:49-52. (Pubitemid 351155911)
27. Song JX, Lin X, Wong RN, Sze SC, Tong Y, Shaw PC, Zhang YB. Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells. Phytother Res 2011;25:435-443.
28. Ip SP, Poon MK, Wu SS, Che CT, Ng KH, Kong YC, Ko KM. Effect of schisandrin B on hepatic glutathione antioxidant system in mice: protection against carbon tetrachloride toxicity. Planta Med 1995;61:398-401.
29. Kim SR, Kang SY, Lee KY, Kim SH, Markelonis GJ, Oh TH, Kim YC. Anti-amnestic activity of E-p-methoxycinnamic acid from Scrophularia buergeriana . Brain Res Cogn Brain Res 2003;17:454-461. (Pubitemid 36869012)
30. Das A, Dikshit M, Nath C. Role of molecular isoforms of acetylcholinesterase in learning and memory functions. Pharmacol Biochem Behav 2005;81:89-99. (Pubitemid 40718956)
31. Ellman GL, Courtney KD, Andres V, Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
32. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fl uids. Anal Biochem 1982;126:131-138. (Pubitemid 13203451)
33. Vincent D, Segonzac G, Vincent MC. [Colorimetric determination of acetylcholine by the Hestrin hydroxylamine reaction and its application in pharmacy.]. Ann Pharm Fr 1958;16: 179-185.
34. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358. (Pubitemid 9194347)
35. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
36. Lankin VZ, Tikhaze AK, Kovalevskaia AL, Lemeshko VV, Vikhert AM. [Age-related changes in the glutathione- S-transferase and glutathione peroxidase activity of rat liver cytosol]. Dokl Akad Nauk SSSR 1981;261:1467-1470.
37. Wakisaka Y, Chu Y, Miller JD, Rosenberg GA, Heistad DD. Spontaneousintracerebral hemorrhage during acute and chronic hypertension in mice. J Cereb Blood Flow Metab 2010;30:56-69.
38. Saito K, Honda S, Tobe A, Yanagiya I. Effects of bifemelane hydrochloride (MCI-2016) on acetylcholine level reduced by scopolamine, hypoxia and ischemia in the rats and mongolian gerbils. Jpn J Pharmacol 1985;38:375-380. (Pubitemid 15030903)
39. Guo LY, Hung TM, Bae KH, Shin EM, Zhou HY, Hong YN, Kang SS, Kim HP, Kim YS. Anti-infl ammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill. Eur J Pharmacol 2008;591:293-299.
40. Bejar C, Wang RH, Weinstock M. Effect of rivastigmine on scopolamine-induced memory impairment in rats. Eur J Pharmacol 1999;383:231-240.
41. Jones RW, Wesnes KA, Kirby J. Effects of NMDA modulation in scopolamine dementia. Ann N Y Acad Sci 1991;640: 241-244.
42. LeDoux JE. Emotional memory systems in the brain. Behav Brain Res 1993;58:69-79.
43. Upchurch M, Wehner JM. Effects of chronic diisopropylfl uorophosphate treatment on spatial learning in mice. Pharmacol Biochem Behav 1987;27:143-151. (Pubitemid 17096852)
44. Giacobini E. Cholinesterases: new roles in brain function and in Alzheimer's disease. Neurochem Res 2003;28:515-522. (Pubitemid 36314842)
45. Adamson ED. Acetylcholinesterase in mouse brain, erythrocytes and muscle. J Neurochem 1977;28:605-615. (Pubitemid 8079321)
46. Massoulie J, Pezzementi L, Bon S, Krejci E, Vallette FM. Molecular and cellular biology of cholinesterases. Prog Neurobiol 1993;41:31-91. (Pubitemid 23140755)
47. Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA. Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 2010;59:290-294.
48. Gilgun-Sherki Y, Melamed E, Offen D. Antioxidant treatment in Alzheimer's disease: current state. J Mol Neurosci 2003;21:1-11. (Pubitemid 37204866)
49. Pong K. Oxidative stress in neurodegenerative disease: therapeutic implications for superoxide dismutase mimetics. Expert Opinion on Biol Therapy 2003;3:127-139. (Pubitemid 36193657)